Amlodipine and edema
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine and Edema: Understanding the Connection
Introduction to Amlodipine and Its Uses
Amlodipine is a widely used calcium channel blocker (CCB) prescribed for the treatment of hypertension and stable coronary artery disease (CAD). Despite its efficacy, amlodipine is often associated with the side effect of peripheral edema, which can limit its use 12.
Incidence and Mechanism of Amlodipine-Induced Edema
High Incidence of Peripheral Edema
Studies have consistently shown that amlodipine significantly increases the risk of peripheral edema compared to placebo. A meta-analysis of randomized, placebo-controlled trials revealed that the rate of edema in patients treated with amlodipine was 16.6%, compared to 6.2% in those receiving a placebo, with a risk ratio of 2.9 12. This indicates a three-fold increase in the risk of edema with amlodipine use.
Mechanism of Edema Formation
The primary mechanism behind amlodipine-induced edema involves arteriolar dilation, which leads to increased capillary pressure and fluid extravasation into the interstitial space 3. This effect is dose-dependent, with higher doses (10 mg) resulting in a greater incidence of edema compared to lower doses (2.5-5 mg) 12.
Comparative Studies: Amlodipine vs. Other CCBs
S(-)-Amlodipine and Reduced Edema
Research comparing conventional amlodipine with its S(-)-enantiomer has shown that the latter may cause less peripheral edema. In a study involving hypertensive patients, those treated with S(-)-amlodipine had a significantly lower incidence of edema compared to those on conventional amlodipine, while maintaining similar antihypertensive efficacy 46.
Amlodipine vs. Lacidipine
Another study compared amlodipine with lacidipine, another CCB, and found that edema occurred more frequently with amlodipine. This was confirmed by quantitative assessments of foot volume, which showed a greater increase in patients on amlodipine 5.
Strategies to Mitigate Amlodipine-Induced Edema
Combination Therapies
Combining amlodipine with other antihypertensive agents can help mitigate edema. For instance, adding a renin-angiotensin inhibitor to amlodipine therapy has been shown to reduce the incidence of edema while achieving better blood pressure control 2. Additionally, the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors has been effective in resolving pedal edema in patients with type 2 diabetes and hypertension on amlodipine 3.
Genetic Factors
Genetic variations, particularly in the CYP3A5 gene, have been linked to the risk of developing amlodipine-induced edema. Certain polymorphisms in this gene can increase the likelihood of edema, suggesting that genetic screening might help identify patients at higher risk 9.
Conclusion
Amlodipine is an effective antihypertensive agent, but its use is often complicated by the side effect of peripheral edema. The risk of edema is dose-dependent and can be influenced by genetic factors. Comparative studies suggest that alternative formulations or combination therapies can reduce the incidence of edema while maintaining efficacy. Understanding these factors can help optimize treatment strategies for patients requiring amlodipine.
Sources and full results
Most relevant research papers on this topic
Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials.
Amlodipine treatment increases the risk of peripheral edema, but up to one-third of edema cases may not be caused by the drug, and headaches are reduced when using low/medium doses.
Meta-Analysis
Very Rigorous Journal1420Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials
Amlodipine treatment for arterial hypertension and stable angina pectoris can cause peripheral edema and headache, but low/medium doses can reduce these side effects.
Meta-Analysis
Rigorous Journal1218-P: Amlodipine-Related Pedal Edema Resolved by Adding Sodium-Glucose Cotransporter 2 Inhibitor: A Technical Co-prescription for Type 2 Diabetes Mellitus with Hypertension
Judicious co-prescription of Amlodipine and SGLT2 inhibitor can prevent fluid overload and pedal edema in diabetes mellitus with hypertension.
RCTRigorous JournalLeg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial
(S)-amlodipine reduces leg edema more effectively than conventional amlodipine in triple therapy for hypertension, with similar antihypertensive efficacy.
RCTRigorous JournalAnkle edema formation during treatment with the calcium channel blockers lacidipine and amlodipine: a single-centre study.
Amlodipine has a higher incidence of edema than lacidipine, possibly due to a higher dose and larger antihypertensive effect.
RCT
The unknown known: non-cardiogenic pulmonary edema in amlodipine poisoning, a cohort study
Non-cardiogenic pulmonary edema (NCPE) is a common finding in significant amlodipine poisoning, occurring in 47% of the cohort and 64% of patients without hemodynamic collapse.
Observational StudyAssociation of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension
CYP3A5 gene polymorphisms are associated with amlodipine-induced peripheral edema in Chinese Han patients with hypertension.
Observational StudyRigorous JournalA Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine
Amlodipine is an effective and well-tolerated antihypertensive for Indians, with greater blood pressure reduction and lower incidence of pedal edema compared to cilnidipine.
Observational StudyVery Rigorous Journal